Eton Pharmaceuticals
(NASDAQ) ETON
Eton Pharmaceuticals Financials at a Glance
Market Cap
$681.84M
Revenue (TTM)
$79.95M
Net Income (TTM)
$4.60M
EPS (TTM)
$-0.18
P/E Ratio
-139.77
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$24.97
Volume
13,676
Open
$24.77
Price
$24.97
Volume
13,676
Open
$24.77
Previous Close
$24.97
Daily Range
$24.61 - $25.47
52-Week Range
$11.09 - $25.99
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$24.97
Volume
13,676
Open
$24.77
Previous Close
$24.97
Daily Range
$24.61 - $25.47
52-Week Range
$11.09 - $25.99
ETON News
ETON: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Eton Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
44
CEO
Sean E. Brynjelsen, MBA
Website
www.etonpharma.comHeadquarters
Deer Park, IL 60010-7208, US
ETON Financials
Key Financial Metrics (TTM)
Gross Margin
53%
Operating Margin
-1%
Net Income Margin
-6%
Return on Equity
-18%
Return on Capital
-2%
Return on Assets
-5%
Earnings Yield
-0.72%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$681.84M
Shares Outstanding
27.28M
Volume
13.68K
Short Interest
0.00%
Avg. Volume
331.41K
Financials (TTM)
Gross Profit
$42.74M
Operating Income
$72.00K
EBITDA
$4.12M
Operating Cash Flow
$10.52M
Capital Expenditure
$333.00K
Free Cash Flow
$10.19M
Cash & ST Invst.
$25.94M
Total Debt
$9.25M
Eton Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$21.28M
+82.7%
Gross Profit
$13.10M
+102.3%
Gross Margin
61.56%
N/A
Market Cap
$681.84M
N/A
Market Cap/Employee
$21.99M
N/A
Employees
31
N/A
Net Income
$1.48M
+348.0%
EBITDA
$3.49M
+254.5%
Quarterly Fundamentals
Net Cash
$16.69M
+211.4%
Accounts Receivable
$11.76M
+119.3%
Inventory
$15.42M
+1.2%
Long Term Debt
$460.00K
-98.5%
Short Term Debt
$8.79M
N/A
Return on Assets
-4.99%
N/A
Return on Invested Capital
-1.57%
N/A
Free Cash Flow
$22.12M
-2747.4%
Operating Cash Flow
$22.07M
-2785.6%